YUHSpace: Dept. of Clinical Pharmacology (임상시험센터)

YUHSpace

BROWSE

YUHSpace7. Others (기타)Dept. of Clinical Pharmacology (임상시험센터)

Dept. of Clinical Pharmacology (임상시험센터)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Verapamil decreases the glucose-lowering effect of metformin in healthy ...

Sung Kweon Cho ; Choon Ok Kim ; Eun Seok Park ; Jae-Yong Chung BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, Vol.78(6) : 1426-1432, 2014

PDF

Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics...

Eun Sil OH ; Choon OK KIM ; Sung Kweon CHO ; Min Soo PARK ; Jae-Yong CHUNG DRUG METABOLISM AND PHARMACOKINETICS, Vol.28(3) : 196-202, 2013

PDF

Functional characterization of MATE2-K genetic variants and their effect...

Chung, Jae-Yong ; Cho, Sung Kweon ; Kim, Tae Hee ; Kim, Kyoung Hee ; Jang, Ge... PHARMACOGENETICS AND GENOMICS, Vol.23(7) : 365-373, 2013

This table browses all dspace content
Issue Date	Title	Journal Title
2020	Association between daily sunlight exposure duration and diabetic retinopathy in Korean adults with diabetes: A nationwide population-based cross-sectional study	PLOS ONE
2020	A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519	PHARMACEUTICS
2020	Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects	Translational and Clinical Pharmacology
2019	Effects of Gelidium elegans on Weight and Fat Mass Reduction and Obesity Biomarkers in Overweight or Obese Adults: A Randomized Double-Blinded Study	Nutrients
2019	The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male	Drug Design, Development and Therapy
2019	Comparison of the Pharmacokinetic-Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers	BioDrugs
2018	A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study	MEDICINE
2018	Coagulant Effect and Tolerability of Yeast-Produced Recombinant Batroxobin in Healthy Adult Subjects	CLINICAL DRUG INVESTIGATION
2018	Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans	Korean J Physiol Pharmacol
2018	Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers	DRUG DESIGN DEVELOPMENT AND THERAPY
2017	Use of a Target-Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC1118, an Anti-epidermal Growth Factor Receptor Antibody	BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
2017	Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis	DRUG DESIGN DEVELOPMENT AND THERAPY
2017	Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis	Translational and Clinical Pharmacology
2017	Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation	SCIENTIFIC REPORTS
2017	Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers	Transl Clin Pharmacol
2017	Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers	JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
2017	Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects	CLINICAL THERAPEUTICS
2016	Comparison of oral absorption models for pregabalin: usefulness of transit compartment model	Drug Des Devel Ther
2016	Effects of JOINS® on the pharmacokinetic profiles of aceclofenac in healthy Korean volunteers: an open-label, multiple-dose, one sequence, two-period study	Translational and Clinical Pharmacology
2016	Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects	DRUG DESIGN DEVELOPMENT AND THERAPY

123

License